Navigation Links
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Date:4/17/2008

better, more-accurate diagnoses."

The sites participating in the first stage of the POET-2 clinical trial program are: 1) University of Alabama, Birmingham, AL, Principal Investigator: Ray Watts, M.D.; 2) University of Arizona Medical Center, Tucson, AZ, Principal Investigator: Scott Sherman, M.D.; 3) Cedars-Sinai Medical Center, Los Angeles, CA, Principal Investigator: Alan Waxman, M.D.; 4) University of Florida McKnight Brain Institute, Gainesville, FL, Principal Investigator: Ramon Rodriguez, M.D.; 5) Dartmouth-Hitchcock Medical Center, Lebanon, NH, Principal Investigator: David Coffey, M.D.; 6) University of Texas Houston Medical School, Houston, TX, Principal Investigator: Mya Schiess, M.D.; 7) University of Texas Southwestern Medical Center, Dallas, TX, Principal Investigator: Padraig O'Suilleabhain, M.D.

"We continue to be optimistic about the diagnostic value that ALTROPANE may represent to those with undiagnosed tremor," commented Dr. Alan Waxman of Cedars Sinai Medical Center, a nuclear-medicine expert, a professor at the University of Southern California, and a principal investigator in the ALTROPANE trial. "As an imaging center, we are pleased with ALTROPANE's high quality scans and rapid imaging process which benefits both the patient and the clinic."

The Tremor Action Network estimates that as many as 10 million people in the United States are afflicted by essential tremor. Experts estimate that, each year, approximately 140,000 individuals present to their physician with new, undiagnosed movement disorders such as Parkinson's Disease and Essential Tremor. In 2002, the European Journal of Neurology reported that there is a 20- to 30-percent misdiagnosis rate in the early stages of Parkinson's disease. Other publications have reported even higher rates of misdiagnosis. The accurate differentiation of Parkinsonian from non-Parkinsonian tremors could allow physicians to initiate earlier referral for specialty care, prescribe effectiv
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 With ... cytometry is experiencing a rise in active partnerships. ... in underdeveloped nations to quantitate CD4 cell markers ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... the Global Flow Cytometry Market ( http://www.frost.com/nf0e ), ...
(Date:8/31/2015)...  The departments of Drug and Alcohol Programs (DDAP) ... 90 to raise awareness for International Overdose Awareness Day ... Pennsylvania and help more Pennsylvanians with substance ... the Building Bridges to Recovery initiative. ... to a disease that is fully treatable, if given ...
(Date:8/31/2015)... Mich. , Aug. 31, 2015  Diplomat Pharmacy, Inc. ... has announced that Phil Hagerman , Chairman & CEO, ... upcoming investor conferences. Mr. Hagerman and Mr. ... Healthcare Conference in Boston on Wednesday, ... Hagerman and Mr. Whelan are also scheduled to participate in ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... -- Keryx,Biopharmaceuticals, Inc. today announced that abstracts ... selected for,publication or presentation during the poster ... American Diabetes Association (ADA) 67th,Annual Scientific Sessions ... in Chicago, Illinois. , Copies of these ...
... 21, 2007 - The,PromegaExpress(TM) on-site stocking program just ... of on-site appliances. This,latest addition serves as great ... areas when space is at a premium,but immediate ... The,mid-sized cabinet can also be stacked with another ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4
(Date:8/31/2015)... Sierra Madre, CA (PRWEB) , ... August 31, ... ... partnered wound center management, recently opened registration for the company’s second Introduction to ... will be held October 15-18, 2015 aboard the Queen Mary Hotel in Long ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence ... , Starting September 1st they are offering pre and postnatal fitness classes ... Body, Healthy Baby." , More information can be found at 248-601-6683. , Women’s ...
(Date:8/31/2015)... FL (PRWEB) , ... August 31, 2015 , ... The ... quality healthcare to Veterans residing across southwest Florida by hiring more doctors and nurses ... the list of expanded services. , In early July, Dr. Anthony Jabre was selected ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State ... 2008, the result of a merger of five of the busiest urology practices ... could provide more cost-effective and higher quality care than they did individually. ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Dr. Paul ... “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders ... traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2
... Making preschool available to all children age three and ... say three Yale scholars who have won the 2008 ... change would improve the school-readiness of the nations young ... high school dropout rate, reduce crime and boost the ...
... study of young women with heart attacksVIRGO (Variation in ... patients)was recently launched at Yale School of Medicine with ... This is the first study to focus on this ... Health Associate Professor Judith Lichtman, co-principal investigator of the ...
... received a renewal of a $1.5 million grant from the ... abilities of elderly drivers. The study is the first of ... natural driving environments. , Under the direction of principal ... Memory Disorders Center at Rhode Island Hospital, 150 older drivers ...
... certify retailers, utilities, financial institutions, ... healthcare organizations and others, ATLANTA, Dec. 18 ... over 2,000 clients, has been,designated as a Qualified Security Assessor ... PCI Security Standards,Council, created by the five major credit card ...
... Urologists Have Performed 15 Different, ... Procedures Include,Single Port Nissen Fundoplication, Colectomy, Prostatectomy ... Novare Surgical Systems,announced the successful completion ... RealHand HD instruments. These ,hidden scar, procedures,require ...
... few years much ballyhooed lunch hour and weekend ... are expected to pursue more reliably effective approaches ... Spiegel, MD, chief of facial plastic and reconstructive ... Boston Medical Center, people are frustrated and ...
Cached Medicine News:Health News:Yale launches landmark VIRGO study of young women with heart disease 2Health News:SecureWorks Designated as a Qualified Security Assessor for PCI Audits 2Health News:Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments 2Health News:Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments 3Health News:Significant changes in plastic surgery expected in 2008 2Health News:Significant changes in plastic surgery expected in 2008 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: